Curta’s CMO, Scott Ramsey, Discusses Cost of Gene Therapy for Sickle Cell Disease in The New Yorker

Resources > News and Events

Curta’s Chief Medical Officer, Scott Ramsey, was quoted in an article by Dhruv Khullar for The New Yorker. The article discusses the advancement of therapies for sickle cell disease over time and the challenges related to accessing gene therapy.

To access the full article, visit:
https://www.newyorker.com/science/annals-of-medicine/are-we-about-to-cure-sickle-cell-disease